Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Swanson

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Neurology|May 29, 2001
Parkinson's disease, CYP2D6 polymorphism, and ageH Payami, N Lee, S Zareparsi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Genetic polymorphisms of superoxide dismutase in Parkinson's diseaseF M Farin, Y Hitosis, S E Hallagan, et al.
JAMA|August 25, 1978
Cooperative study of hospital frequency and character of transient ischemic attacks. VIII. Risk factorsP M Conneally, M L Dyken, D E Futty, et al.
Cell|January 15, 1993
DNA deletion associated with hereditary neuropathy with liability to pressure palsiesP F Chance, M K Alderson, K A Leppig, et al.
Pharmacogenetics|November 3, 2001
Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's diseaseF M Farin, P Janssen, S Quigley, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2003
Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's diseaseS N Kelada, P Costa-Mallen, H Checkoway, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Neurology|May 29, 2001
Parkinson's disease, CYP2D6 polymorphism, and ageH Payami, N Lee, S Zareparsi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Genetic polymorphisms of superoxide dismutase in Parkinson's diseaseF M Farin, Y Hitosis, S E Hallagan, et al.
JAMA|August 25, 1978
Cooperative study of hospital frequency and character of transient ischemic attacks. VIII. Risk factorsP M Conneally, M L Dyken, D E Futty, et al.
Cell|January 15, 1993
DNA deletion associated with hereditary neuropathy with liability to pressure palsiesP F Chance, M K Alderson, K A Leppig, et al.
Pharmacogenetics|November 3, 2001
Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's diseaseF M Farin, P Janssen, S Quigley, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2003
Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's diseaseS N Kelada, P Costa-Mallen, H Checkoway, et al.
Pageof 7